Nathanael S. Gray,Michael Eck,Pasi Janne,Hwan Geun Choi,Jaebong Jang,Kwok-Kin Wong
申请号:
US15580088
公开号:
US10385019B2
申请日:
2016.06.30
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The disclosure relates to a compound having Formula (I′;):andin particular, Compound I-126:which modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role.